Gregory M Weinhoff Centessa Pharmaceuticals PLC (CNTA) insider trading activity

Gregory M Weinhoff is Chief Business Officer of Centessa Pharmaceuticals plc. Currently has a direct ownership of 223,369 shares of CNTA, which is worth approximately $3.8 Million. The most recent transaction as insider was on Sep 10, 2024, when has been sold 30,000 shares (Ordinary Shares) at a price of $17.0 per share, resulting in proceeds of $510,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 223K

15.75% 3M change

20.39% 12M change

Total Value Held $3.8 Million

Gregory M Weinhoff Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 10 2024	SELL Open market or private sale	$510,000 $17.0 p/Share	30,000 Reduced 11.84%	223,369 Ordinary Shares
Sep 10 2024	BUY Exercise of conversion of derivative security	$175,200 $5.84 p/Share	30,000 Added 10.59%	253,369 Ordinary Shares
Sep 09 2024	SELL Open market or private sale	$375,000 $15.0 p/Share	25,000 Reduced 10.07%	223,369 Ordinary Shares
Sep 09 2024	BUY Exercise of conversion of derivative security	$146,000 $5.84 p/Share	25,000 Added 9.15%	248,369 Ordinary Shares
Aug 23 2024	SELL Open market or private sale	$218,786 $12.29 p/Share	17,802 Reduced 7.38%	223,369 Ordinary Shares
Aug 22 2024	SELL Open market or private sale	$148,449 $12.17 p/Share	12,198 Reduced 4.81%	241,171 Ordinary Shares
Jun 30 2024	SELL Payment of exercise price or tax liability	$106,030 $9.03 p/Share	11,742 Reduced 4.43%	253,369 Ordinary Shares
Mar 31 2024	SELL Payment of exercise price or tax liability	$132,684 $11.3 p/Share	11,742 Reduced 4.24%	265,111 Ordinary Shares
Feb 01 2024	SELL Payment of exercise price or tax liability	$94,135 $8.19 p/Share	11,494 Reduced 3.99%	276,853 Ordinary Shares
Feb 01 2024	BUY Grant, award, or other acquisition	-	31,250 Added 9.78%	288,347 Ordinary Shares
Dec 31 2023	SELL Payment of exercise price or tax liability	$93,466 $7.96 p/Share	11,742 Reduced 4.37%	257,097 Ordinary Shares
Sep 30 2023	SELL Payment of exercise price or tax liability	$75,970 $6.47 p/Share	11,742 Reduced 4.18%	268,839 Ordinary Shares
Jun 30 2023	SELL Payment of exercise price or tax liability	$69,277 $5.9 p/Share	11,742 Reduced 4.02%	280,581 Ordinary Shares
Mar 31 2023	SELL Payment of exercise price or tax liability	$32,338 $3.9 p/Share	8,292 Reduced 2.76%	292,323 Ordinary Shares
Feb 01 2023	BUY Grant, award, or other acquisition	-	77,200 Added 20.43%	300,615 Ordinary Shares
Dec 31 2022	SELL Payment of exercise price or tax liability	$16,439 $3.1 p/Share	5,303 Reduced 2.21%	234,697 Ordinary Shares
Oct 03 2022	SELL Open market or private sale	$19,359 $3.95 p/Share	4,901 Reduced 2.08%	231,099 Ordinary Shares
Sep 30 2022	SELL Payment of exercise price or tax liability	$47,948 $4.25 p/Share	11,282 Reduced 4.7%	228,718 Ordinary Shares
Sep 30 2022	SELL Open market or private sale	$16,280 $4.07 p/Share	4,000 Reduced 1.67%	236,000 Ordinary Shares
Jul 01 2022	BUY Grant, award, or other acquisition	-	230,000 Added 48.94%	240,000 Ordinary Shares
Jun 02 2021	BUY Open market or private purchase	$200,000 $20.0 p/Share	10,000 Added 50.0%	10,000 Ordinary Shares

GMW

Gregory M Weinhoff

Chief Business Officer

Cheshire, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNTA shares.

Notify only if

Value

Insider Trading

Get notified when an Centessa Pharmaceuticals PLC insider buys or sells CNTA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Centessa Pharmaceuticals plc

Track Activities on CNTA

Account